Cover Image
市場調查報告書

全球乳癌市場:產業分析與預測

Global Breast Cancer Market: Industry Analysis & Outlook 2018-2022

出版商 Koncept Analytics 商品編碼 204467
出版日期 內容資訊 英文 82 Pages
訂單完成後即時交付
價格
Back to Top
全球乳癌市場:產業分析與預測 Global Breast Cancer Market: Industry Analysis & Outlook 2018-2022
出版日期: 2018年03月29日 內容資訊: 英文 82 Pages
簡介

本報告提供全球乳癌市場相關調查分析,美國,歐洲,亞太地區為焦點,成長推動因素與課題,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

  • 乳癌
  • 種類
  • 分期
  • 危險因素
  • 症狀、診斷
  • 治療

第2章 全球乳癌市場

  • 全球乳癌市場:各金額
  • 全球乳癌市場預測:各金額
  • 全球乳癌市場:各地區
  • 全球乳癌治療藥開發:各病期

第3章 各地區的乳癌市場分析

  • 美國
  • 歐洲
  • 亞太地區

第4章 市場動態

  • 成長促進因素
  • 主要趨勢與發展
  • 課題

第5章 競爭情形

  • 全球市場

第6章 企業簡介

  • Johnson & Johnson
    • 產業概要
    • 財務概要
    • 事業策略
  • AstraZeneca
    • 產業概要
    • 財務概要
    • 事業策略
  • AbbVie Inc.
    • 產業概要
    • 財務概要
    • 事業策略
  • Roche
    • 產業概要
    • 財務概要
    • 事業策略

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

'Breast cancer' defines a malignant tumor that has developed from cells in the breast. Some breast cancers are called in situ as they are confined within the ducts (ductal carcinoma in situ or DCIS) or lobules (lobular carcinoma in situ or LCIS) where they originated. Although, less commonly, breast cancer can also instigate in the stromal tissues, which includes the fatty and fibrous connective tissues of the breast. In the early stages, breast cancer may not cause any symptoms. A lump may be too small to feel or to cause any unusual changes that could be noticed on own. Typically, an abnormal area shows up on a screening mammogram which leads to further testing. Several risk factors including smoking and alcohol consumption, exposure to estrogen, gender, age, family history and personal history are linked to the growth of breast cancer.

The global breast cancer market is likely to grow strongly in the coming years driven by rising healthcare expenditure, rising diabetic and obese population, increasing consumption of alcohol and tobacco and rising female population above 65 years of age. Key trends of the market includes rising development of PARP inhibitors, increasing adoption of minimally invasive procedures and rising awareness programs and research grants. However, growth of the market can be hindered by several factors including financial burden of breast cancer, drug development challenges in developing countries, long term side effects of drugs.

The report "Global Breast Cancer Market: Industry Analysis & Outlook (2018-2022)" by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the US, Europe and APAC regions along with the global market. The report profiles the key players of the market including Johnson & Johnson, AbbVie, AstraZeneca and Roche.

Table of Contents

1. Introduction

  • 1.1 Breast Cancer
  • 1.2 Types
  • 1.3 Stages
  • 1.4 Risk Factors
  • 1.4 Symptoms & Diagnosis
  • 1.5 Treatment

2. Global Breast Cancer Market

  • 2.1 Global Breast Cancer Market by Value
  • 2.2 Global Breast Cancer Market Forecast by Value
  • 2.3 Global Breast Cancer Market by Region
  • 2.4 Global Breast Cancer Drug Development by Stages

3. Regional Breast Cancer Market Analysis

  • 3.1 The U.S.
    • 3.1.1 The U.S. Breast Cancer Market by Value
    • 3.1.2 The U.S. Breast Cancer Market Forecast by Value
    • 3.1.3 The U.S. Breast Cancer Market by Addressable Population
    • 3.1.4 The U.S. Breast Cancer Market Forecast by Addressable Population
    • 3.1.5 The U.S. Breast Cancer Population by Age
    • 3.1.6 The US HER2+ Node Positive Breast Cancer Patients Volume
    • 3.1.7 The US HER2+ Node Negative Breast Cancer Patients Volume
    • 3.1.8 The US HER2+ Node Negative (High Risk) Breast Cancer Patients Volume
  • 3.2 Europe
    • 3.2.1 EU5 Breast Cancer Market by Value
    • 3.2.2 EU5 Breast Cancer Market Forecast by Value
    • 3.2.3 Europe HER2+ Node Positive Breast Cancer Patients Volume
    • 3.2.4 Europe HER2+ Node Negative Breast Cancer Patients Volume
    • 3.2.5 Europe HER2+ Node Negative (High Risk) Breast Cancer Patients Volume
  • 3.3 APAC
    • 3.3.1 APAC Breast Cancer Market by Value
    • 3.3.2 APAC Breast Cancer Market Forecast by Value
    • 3.3.3 APAC Breast Cancer Market by Countries
    • 3.3.4 Japan's Breast Cancer Market by Value
    • 3.3.5 Japan's Breast Cancer Market Forecast by Value
    • 3.3.6 China's Breast Cancer Market by Value
    • 3.3.7 China's Breast Cancer Market Forecast by Value
    • 3.3.8 Australia's Breast Cancer Market by Value
    • 3.3.9 Australia's Breast Cancer Market Forecast by Value

4. Market Dynamics

  • 4.1 Growth Drivers
    • 4.1.1 Rising Consumption of Tobacco and Alcohol
    • 4.1.2 Increasing Global Diabetic Population
    • 4.1.3 Accelerating Obese Population
    • 4.1.4 Increasing Healthcare Expenditure Per Capita
    • 4.1.5 Rising Female Population Aged 65 Years & Above
  • 4.2 Key Trends & Developments
    • 4.2.1 PARP Inhibitors under Development
    • 4.2.32Rising Adoption of Minimally Invasive Procedures
    • 4.2.3 Increasing Awareness Programs and Research Grants
  • 4.3 Challenges
    • 4.3.1 Financial Burden of Breast Cancer
    • 4.3.2 Drug Development Challenges in Developing Countries
    • 4.3.3 Long Term Side Effects

5. Competition

  • 5.1 Global Market
    • 5.1.1 Revenue Comparison by Company
    • 5.1.2 R&D Expenditure Comparison by Company
    • 5.1.3 Market Cap Comparison by Company

6. Company Profiles

  • 6.1 Johnson & Johnson
    • 6.1.1 Business Overview
    • 6.1.2 Financial Overview
    • 6.1.3 Business Strategies
  • 6.2 AstraZeneca
    • 6.2.1 Business Overview
    • 6.2.2 Financial Overview
    • 6.2.3 Business Strategies
  • 6.3 AbbVie Inc.
    • 6.3.1 Business Overview
    • 6.3.2 Financial Overview
    • 6.3.3 Business Strategies
  • 6.4 Roche
    • 6.4.1 Business Overview
    • 6.4.2 Financial Overview
    • 6.4.3 Business Strategies

List of Charts

  • Breast Cancer by Types
  • Stage Occurrence of Breast Cancer in Patients
  • Global Breast Cancer Market by Value (2013-2017)
  • Global Breast Cancer Market Forecast by Value (2018-2022)
  • Global Breast Cancer Market by Region (2017)
  • Global Breast Cancer Drug Development by Stages (2017)
  • The U.S. Breast Cancer Market by Value (2013-2017)
  • The U.S. Breast Cancer Market Forecast by Value (2018-2022)
  • The U.S. Breast Cancer Market by Addressable Population (2013-2017)
  • The U.S. Breast Cancer Market Forecast by Addressable Population (2018-2022)
  • The U.S. Breast Cancer Population by Age & Type (2017)
  • The U.S. HER2+ Node Positive Breast Cancer Patients Volume (2017-2022)
  • The U.S. HER2+ Node Negative Breast Cancer Patients Volume (2017-2022)
  • The U.S. HER2+ Node Negative (High Risk) Breast Cancer Patients Volume (2017-2022)
  • EU5 Breast Cancer Market by Value (2013-2017)
  • EU5 Breast Cancer Market Forecast by Value (2018-2022)
  • Europe HER2+ Node Positive Breast Cancer Patients Volume (2017-2022)
  • Europe HER2+ Node Negative Breast Cancer Patients Volume (2017-2022)
  • Europe HER+ Node Negative (High Risk) Breast Cancer Patients Volume (2017-2022)
  • APAC Breast Cancer Market by Value (2013-2017)
  • APAC Breast Cancer Market Forecast by Value (2018-2022)
  • APAC Breast Cancer Market by Countries (2017)
  • Japan's Breast Cancer Market by Value (2013-2017)
  • Japan's Breast Cancer Market Forecast by Value (2018-2022)
  • China's Breast Cancer Market by Value (2013-2017)
  • China's Breast Cancer Market Forecast by Value (2018-2022)
  • Australia's Breast Cancer Market by Value (2013-2017)
  • Australia's Breast Cancer Forecast Market by Value (2018-2022)
  • Global Cigarette Consumption (1990-2017)
  • Global Diabetic Population (2013-2017)
  • Global Obese Population (2013-2017)
  • Global Healthcare Expenditure Per Capita (2013-2017)
  • Global Female Population Aged 65 Years and Above (2013-2017)
  • Revenue Comparison by Company (2017)
  • R&D Expenditure Comparison by Company (2017)
  • Market Cap Comparison by Company (2017)
  • Johnson & Johnson Sales by Segments (2017)
  • Johnson & Johnson Sales and Net Earnings (2013-2017)
  • AstraZeneca Product Revenue by Region (2017)
  • AstraZeneca Revenue and Net Profit (2013-2017)
  • AstraZeneca Development Pipeline Overview (2017)
  • AbbVie Revenue by Product Segments (2017)
  • AbbVie Revenue and Net Earnings (2013-2017)
  • Roche Sales by Segments (2017)
  • Roche Sales and Net Income (2013-2017)

List of Tables

  • Stages of Breast Cancer
  • Key PARP Inhibitors Under Development (2017)
  • Johnson & Johnson Product Pipeline (2017)
  • AbbVie Inc. Agreements (2017/2018)
  • AbbVie Inc. Major Product Approvals (2017/2018)
  • Roche Agreements (2017/2018)
  • Roche Product Approvals & Launches (2017/2018)
Back to Top